Vir Biotechnology
VIR
VIR
164 hedge funds and large institutions have $3.64B invested in Vir Biotechnology in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 65 increasing their positions, 32 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
+8
Holders Change %
+5.13%
% of All Funds
2.86%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
39
Increased
65
Reduced
32
Closed
30
Calls
$29.3M
Puts
$20.6M
Net Calls
+$8.71M
Net Calls Change
+$16.4M
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$24.6M |
| 2 |
2
BlackRock
New York
|
$236M |
| 3 |
MM
3
MWG Management
Road Town, Tortola,
British Virgin Islands
|
$3.53M |
| 4 |
4
Norges Bank
Oslo,
Norway
|
$13.8M |
| 5 |
N
5
Natixis
Paris,
France
|
$0 |
